United States · FDA National Drug Code directory
Prolastin-C Liquid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13533-705_f3f69bd6-df32-45c4-bbd9-b18b0d725382
- Product NDC
- 13533-705
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Alpha1-Proteinase Inhibitor (Human)
- Labeler
- GRIFOLS USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19871202
- Source listing expiry
- 20261231
Source-listed ingredients
- .ALPHA.1-PROTEINASE INHIBITOR HUMAN — 1000 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (13533-705-01) / 20 mL in 1 VIAL (13533-705-11) · 13533-705-01
- 1 VIAL in 1 CARTON (13533-705-31) / 10 mL in 1 VIAL (13533-705-32) · 13533-705-31
- 1 VIAL in 1 CARTON (13533-705-51) / 80 mL in 1 VIAL (13533-705-52) · 13533-705-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →